Patents by Inventor Nir Hecht

Nir Hecht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OMNI-103 CRISPR NUCLEASE
    Publication number: 20250051741
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: March 22, 2024
    Publication date: February 13, 2025
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht
  • Omni-103 CRISPR Nuclease-RNA Complexes
    Publication number: 20250034596
    Abstract: A composition comprising a non-naturally occurring RNA molecule, the RNA molecule comprising an RNA scaffold portion, the RNA scaffold portion having the structure: crRNA repeat sequence portion-tracrRNA portion: wherein the RNA scaffold portion forms a complex with and targets an OMNI-103 CRISPR nuclease to a DNA target site having complementarity to a guide sequence portion of the RNA molecule.
    Type: Application
    Filed: December 6, 2022
    Publication date: January 30, 2025
    Inventors: Lior IZHAR, Liat ROCKAH, Nadav MARBACH BAR, Nir HECHT
  • OMNI 263, 264, 266, 268, 269, 271, 274, 275, 276, 278, 279, 280, 281, 283, 284, 286, 287, 288, 290, 291, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 329, 330, 331, 332, 333, 334, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 375, 376,
    Publication number: 20250011741
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NOs: 1-108 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: November 17, 2022
    Publication date: January 9, 2025
    Applicant: EMENDOBIO INC
    Inventors: Lior IZHAR, Nadav MARDACH BAR, Liat ROCKAH, Nir HECHT, Sigal COHEN, Nurit MERON, Ophir ADIV, Ariel GISPAN, Idit BUCH
  • OMNI-103 CRISPR nuclease
    Patent number: 12091688
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: September 17, 2024
    Assignee: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht
  • OMNI-103 CRISPR NUCLEASE
    Publication number: 20230303989
    Abstract: The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
    Type: Application
    Filed: February 7, 2022
    Publication date: September 28, 2023
    Applicant: EmendoBio Inc.
    Inventors: Lior Izhar, Nadav Marbach Bar, Liat Rockah, Nurit Meron, Ophir Adiv Tal, Ariel Gispan, Idit Buch, Nir Hecht